These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2965570)

  • 41. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-acting injectable contraception with depot medroxyprogesterone acetate.
    Kaunitz AM
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive cervical cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Thomas DB; Noonan L; Whitehead A; Roseman D
    Bull World Health Organ; 1985; 63(3):505-11. PubMed ID: 2931205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results.
    Grossman RA; Asawasena W; Chalpati S; Taewtong D; Tovanabutra S
    Bull World Health Organ; 1979; 57(5):829-37. PubMed ID: 161523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Facts about injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1982; 60(2):199-210. PubMed ID: 6213318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contraception in the later reproductive years: a valid aspect of preventive health care.
    Speroff L; Sulak PJ
    Dialogues Contracept; 1995; 4(5):1-4. PubMed ID: 12288679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statement on injectable contraception.
    International Planned Parenthood Federation IPPF
    IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation.
    Pardthaisong T; Yenchit C; Gray R
    Contraception; 1992 Apr; 45(4):313-24. PubMed ID: 1387602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
    Ertopçu K; Inal MM; Ozelmas I
    Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Program- and method-related determinants of first DMPA use duration in rural Bangladesh.
    Riley AP; Stewart MK; Chakraborty J
    Stud Fam Plann; 1994; 25(5):255-67. PubMed ID: 7871551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Thomas DB; Noonan L; Whitehead A
    Bull World Health Organ; 1985; 63(3):513-9. PubMed ID: 2931206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
    Dahlberg K
    Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galactorrhea in DMPA users: incidence and clinical significance.
    Gongsakdi D; Rojanasakul A
    J Med Assoc Thai; 1986 Jan; 69(1):28-32. PubMed ID: 2937870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously.
    Segall-Gutierrez P; Taylor D; Liu X; Stanzcyk F; Azen S; Mishell DR
    Contraception; 2010 Jun; 81(6):487-95. PubMed ID: 20472115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: results after six months.
    Grossman RA; Assawasena V; Chalpati S; Taewtong D
    Bull World Health Organ; 1977; 55(1):67-78. PubMed ID: 302157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medroxyprogesterone acetate as a contraceptive for female drug addicts.
    Mark I
    Scand J Soc Med; 1983; 11(3):75-80. PubMed ID: 6230717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.